Cargando…

Preclinical Models of Adrenocortical Cancer

SIMPLE SUMMARY: Adrenocortical cancer is a very rare form of endocrine cancer with dismal prognosis. Preclinical models such as cell lines, organoids, and mouse models are essential for both improving basic understanding of this disease and developing treatments. Herein, we review a currently availa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sedlack, Andrew J. H., Hatfield, Samual J., Kumar, Suresh, Arakawa, Yasuhiro, Roper, Nitin, Sun, Nai-Yun, Nilubol, Naris, Kiseljak-Vassiliades, Katja, Hoang, Chuong D., Bergsland, Emily K., Hernandez, Jonathan M., Pommier, Yves, del Rivero, Jaydira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251941/ https://www.ncbi.nlm.nih.gov/pubmed/37296836 http://dx.doi.org/10.3390/cancers15112873

Ejemplares similares

The Immunotherapy Landscape in Adrenocortical Cancer
por: Pegna, Guillaume J., et al.
Publicado: (2021)

Preclinical Models of Neuroendocrine Neoplasia
por: Sedlack, Andrew J. H., et al.
Publicado: (2022)

Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer
por: Laha, Dipranjan, et al.
Publicado: (2022)

Current Status and Future Targeted Therapy in Adrenocortical Cancer
por: Alyateem, George, et al.
Publicado: (2021)

New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications
por: Jhawar, Sakshi, et al.
Publicado: (2022)

Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer
por: Michael, Nicholas, et al.
Publicado: (2022)

Pediatric adrenocortical carcinoma
por: Ilanchezhian, Maran, et al.
Publicado: (2022)

SAT-LB064 Mitotane Induces Autophagy: A Mechanism to Promote Chemoresistance in Adrenocortical Carcinoma
por: Tompkins, Kenneth, et al.
Publicado: (2019)

SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019)

Adrenocortical carcinoma and pulmonary embolism from tumoral extension
por: Shekhar, Skand, et al.
Publicado: (2019)

Association of Cigarette Smoking with Aberrant Methylation of the Tumor Suppressor Gene RARβ2 in Papillary Thyroid Cancer
por: Kiseljak-Vassiliades, Katja, et al.
Publicado: (2011)

Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer
por: Head, Lia, et al.
Publicado: (2019)

Leptomeningeal Metastasis from Adrenocortical Carcinoma: A Case Report
por: Schreiber, Anna R, et al.
Publicado: (2020)

FRI199 Severe Hypertriglyceridemia And Acute Pancreatitis In A Patient With Adrenocortical Carcinoma (ACC) Taking Mitotane
por: Cortez, Briana Noel, et al.
Publicado: (2023)

SUN-337 Anti-tumorigenic Effects Of The Maternal Leucine Zipper Kinase (MELK) Inhibitor, OTSSP167, In Pre-clinical In Vivo Models Of Adrenocortical Carcinomas (ACC)
por: KAR, ADWITIYA, et al.
Publicado: (2019)

RF07 | PSUN356 Synergistic Combination of HSP90 and PI3K inhibitors in Adrenocortical Cancer
por: Mishra, Prachi, et al.
Publicado: (2022)

Insights From Targeted Genetic Analysis of 364 Adrenocortical Carcinomas
por: Pozdeyev, Nikita, et al.
Publicado: (2021)

Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction
por: Weigand, Isabel, et al.
Publicado: (2020)

SUN-211 Active Steroid Hormone Synthesis Renders Adrenocortical Cells Highly Susceptible to Type II Ferroptosis Induction
por: Weigand, Isabel, et al.
Publicado: (2020)

Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening
por: Nilubol, Naris, et al.
Publicado: (2012)

Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
por: Xie, Changqing, et al.
Publicado: (2018)

Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response
por: Nilubol, Naris, et al.
Publicado: (2018)

Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine Tumors
por: Varghese, Diana Grace, et al.
Publicado: (2023)

Editorial: Molecular Mechanisms in Cancer Endocrinology With Clinical Implications
por: Nilubol, Naris
Publicado: (2022)

Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma
por: Shetty, Impana, et al.
Publicado: (2019)

Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
por: Fojo, Tito, et al.
Publicado: (2020)

Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome
por: Boufraqech, Myriem, et al.
Publicado: (2019)

Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET
por: Raygada, Margarita, et al.
Publicado: (2021)

OR08-02 In Situ Reconstruction Of Distinct Normal And Pathological Cell Populations Within The Human Adrenal Gland Using Spatial Transcriptomics
por: Rui, Fu, et al.
Publicado: (2023)

PMON127 Neuroendocrine Tumor of the Spinal Cord- A Case Report of Rare Endocrine Tumor Presentation
por: Varghese, Diana Grace, et al.
Publicado: (2022)

New Therapies for Advanced Thyroid Cancer
por: Laha, Diprajan, et al.
Publicado: (2020)

PSAT387 An Unusual Case of Sporadic Metastatic Medullary Thyroid Cancer Without a Primary Tumor Presenting with Paraneoplastic Cushing's Syndrome
por: Jumani, Sanjay, et al.
Publicado: (2022)

OR04-6 Comprehensive Profiling of the MELK Inhibitor OTSSP167's Action and Its Effect on Sensitization to Wee1 Inhibitor AZD1775 in a Spectrum of ACC Models
por: Bagby, Stacey, et al.
Publicado: (2022)

Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma
por: Fuller, Sarah N., et al.
Publicado: (2021)

Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure
por: Libutti, Steven K., et al.
Publicado: (2018)

SAT179 Germline And Somatic Inactivating FLCN Variants In Parathyroid Cancer and Atypical Parathyroid Tumors
por: Jha, Smita, et al.
Publicado: (2023)

MON-320 Lost in the Rugae: High Grade Gastric Neuroendocrine Tumor in an MEN1 Patient with Zollinger-Ellison Syndrome
por: Bansal, Rashika, et al.
Publicado: (2019)

Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer
por: Mishra, Prachi, et al.
Publicado: (2021)

The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment
por: Laha, Dipranjan, et al.
Publicado: (2021)

Is VTE Prophylaxis Necessary on Discharge for Patients Undergoing Adrenalectomy for Cushing Syndrome?
por: Babic, Bruna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nlvfk5b3eo9b91iogb9oi9eitb